Loading...

Alterations of biomarker profiles after neoadjuvant chemotherapy in breast cancer: tumor heterogeneity should be taken into consideration

Tumor biomarkers including estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2) and Ki-67 are routinely tested in breast cancer patients and their status guides clinical management and predicts prognosis. A few retrospective studies have suggested that...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncotarget
Main Authors: Zhou, Xingchen, Zhang, Junyong, Yun, Haiqin, Shi, Ranran, Wang, Yan, Wang, Wei, Lagercrantz, Svetlana Bajalica, Mu, Kun
Format: Artigo
Sprog:Inglês
Udgivet: Impact Journals LLC 2015
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4742218/
https://ncbi.nlm.nih.gov/pubmed/26384297
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!